Sumitomo Pharma Co., Ltd.
4506.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥23 | ¥29 | ¥143 | ¥203 |
| Short-Term Investments | ¥17 | ¥7 | ¥0 | ¥0 |
| Receivables | ¥75 | ¥97 | ¥96 | ¥151 |
| Inventory | ¥94 | ¥115 | ¥94 | ¥99 |
| Other Curr. Assets | ¥44 | ¥37 | ¥48 | ¥46 |
| Total Curr. Assets | ¥253 | ¥270 | ¥382 | ¥500 |
| Property Plant & Equip (Net) | ¥47 | ¥58 | ¥59 | ¥64 |
| Goodwill | ¥197 | ¥200 | ¥209 | ¥195 |
| Intangibles | ¥173 | ¥196 | ¥329 | ¥399 |
| Long-Term Investments | ¥57 | ¥162 | ¥114 | ¥128 |
| Tax Assets | ¥1 | ¥0 | ¥11 | ¥23 |
| Other NC Assets | ¥16 | ¥23 | ¥31 | ¥0 |
| Total NC Assets | ¥489 | ¥638 | ¥753 | ¥808 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥743 | ¥908 | ¥1,135 | ¥1,308 |
| Liabilities | – | – | – | – |
| Payables | ¥39 | ¥68 | ¥13 | ¥22 |
| Short-Term Debt | ¥46 | ¥286 | ¥91 | ¥25 |
| Tax Payable | ¥2 | ¥1 | ¥24 | ¥8 |
| Deferred Revenue | ¥0 | ¥0 | ¥152 | ¥140 |
| Other Curr. Liab. | ¥154 | ¥158 | ¥240 | ¥202 |
| Total Curr. Liab. | ¥241 | ¥515 | ¥373 | ¥278 |
| LT Debt | ¥259 | ¥133 | ¥244 | ¥244 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥17 | ¥28 |
| Deferred Tax Liab, NC | ¥27 | ¥38 | ¥37 | ¥27 |
| Other NC Liab. | ¥42 | ¥59 | ¥51 | ¥48 |
| Total NC Liab. | ¥333 | ¥236 | ¥355 | ¥356 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥5 | ¥7 | ¥10 |
| Total Liabilities | ¥573 | ¥751 | ¥728 | ¥634 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥22 | ¥22 | ¥22 | ¥22 |
| Retained Earnings | ¥47 | -¥23 | ¥281 | ¥514 |
| AOCI | ¥101 | ¥157 | ¥104 | ¥55 |
| Other Equity | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Equity | ¥169 | ¥156 | ¥407 | ¥608 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥66 |
| Total Liab. & Tot. Equity | ¥743 | ¥908 | ¥1,135 | ¥1,308 |
| Net Debt | ¥282 | ¥390 | ¥191 | ¥66 |